IGF2BP2 and non-small cell lung carcinoma: The interaction between circNDUFB2 and IMPs was validated through RNA immunoprecipitation and RNA pull-down assays, while in vivo xenograft studies demonstrated that circNDUFB2 overexpression reduced tumor growth and increased immune cell infiltration, highlighting the role of IMP2 in immune activation in NSCLC.